Veracyte Announces Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Veracyte (VCYT) Halted on LUDP
November 7, 2017 9:31 AM ESTVeracyte (NASDAQ: VCYT) Halted on LUDP
... MoreVeracyte, Inc (VCYT) PT Lowered to $9 at Leerink Partners
November 7, 2017 8:10 AM ESTLeerink Partners lowered its price target on Veracyte, Inc (NASDAQ: VCYT) to $9.00 (from $12.00) while maintaining an Outperform rating following lower than expected Q3 revenue and guidance.
Analyst Puneet Souda is keeping the Outperform rating on the view that the company offers differentiated negative... More
Veracyte (VCYT) Tops Q3 EPS by 2c
November 6, 2017 4:19 PM ESTVeracyte (NASDAQ: VCYT) reported Q3 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $19.55 million.
We delivered a solid performance this quarter in which we grew our genomic test... More
